Braided Antegrade Perfusion Assembly for De-Airing and Flow Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antegrade perfusion systems for cardiogenic shock patients face limitations such as clot formation, flow restrictions due to stopcocks, and increased risk of limb ischemia, which can lead to severe complications like amputation.

Innovation Solution

An antegrade perfusion assembly comprising a braided sheath, a three-way stopcock, and a male-to-male connection, designed to enhance perfusate flow, reduce kinking, and provide precise control and de-airing, ensuring a secure and leak-free interface for oxygenated blood perfusion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If a three-way stopcock is used to control perfusate flow, then flow control is improved, but the stopcock becomes a limiting reagent that impedes flow and increases clot formation risk

Engineering Contradiction:
Improveflow controlVSAvoidflow restriction and clot formation risk
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent removes the three-way stopcock from the antegrade perfusion circuit entirely, extracting the flow control function from a component that was causing flow restriction and clot formation. The system uses a direct connection between the femoral artery and the perfusion catheter, eliminating the stopcock's limiting effect on blood flow while maintaining the ability to control perfusate delivery through alternative means.

Inventive Principle:
Principle #2Taking out (Extraction)

2Ease of operation

If standard catheters are used for antegrade perfusion, then limb perfusion is attempted, but clot formation occurs leading to suboptimal perfusion and device discontinuation

Engineering Contradiction:
Improvelimb perfusion capabilityVSAvoidclot formation and perfusion effectiveness
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent incorporates a pre-flush mechanism that flushes the perfusion catheter with heparinized saline before and during use. This preliminary action prevents clot formation by maintaining continuous flow and preventing stasis in the catheter lumen, thereby ensuring reliable limb perfusion and reducing the risk of device discontinuation due to thrombotic complications.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If large bore access is used for mechanical circulatory support devices, then cardiac support is provided, but limb ischemia risk increases

Engineering Contradiction:
Improvecardiac support effectivenessVSAvoidlimb ischemia risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses a femoral artery catheter as an intermediary pathway to deliver perfusate to the limb. This approach allows mechanical circulatory support to be provided through the femoral artery while using the same catheter as a controlled delivery route for perfusion, thereby preventing limb ischemia by ensuring adequate blood flow through the affected artery while maintaining cardiac support.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS20250381388A1Antegrade perfusion assembly
Publication Date: 2025.12.18 NARULA HEALTH CARE CONSULTANTS LLC
  • US20250381388A1 patent drawing

AI summary

An antegrade perfusion assembly may have a braided sheath, a three-way stopcock, and a male-to-male connection. The three-way stopcock can fluidly communicate with the braided sheath in assembly. The three-way stopcock can furnish control of perfusate flow amid use of the antegrade perfusion assembly, and can facilitate de-airing of the braided sheath amid use of the antegrade perfusion assembly. The male-to-male connection can fluidly communicate with the three-way stopcock, and can accept reception and securement with an oxygenated blood source amid use of the antegrade perfusion assembly.